Cholinergic	cholinergic	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
resulting	resulting	O	O	O	O
from	from	O	O	O	O
ocular	ocular	O	O	O	O
instillation	instillation	O	O	O	O
of	of	O	O	O	O
echothiophate	echothiophate	CHEMICALS	O	OTHERS	I
iodide	iodide	CHEMICALS	O	OTHERS	I
eye	eye	O	O	O	O
drops	drops	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
patient	patient	O	O	O	O
developed	developed	O	O	O	O
a	a	O	O	O	O
severe	severe	O	O	O	O
cholinergic	cholinergic	O	O	O	O
syndrome	syndrome	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
echothiophate	echothiophate	CHEMICALS	O	OTHERS	I
iodide	iodide	CHEMICALS	O	OTHERS	I
ophthalmic	ophthalmic	O	O	O	O
drops	drops	O	O	O	O
,	,	O	O	O	O
presented	presented	O	O	O	O
with	with	O	O	O	O
profound	profound	O	O	O	O
muscle	muscle	O	DISEASE	OTHERS	I
weakness	weakness	O	DISEASE	OTHERS	I
and	and	O	O	O	O
was	was	O	O	O	O
initially	initially	O	O	O	O
given	given	O	O	O	O
the	the	O	O	O	O
diagnosis	diagnosis	O	O	O	O
of	of	O	O	O	O
myasthenia	myasthenia	O	DISEASE	OTHERS	I
gravis	gravis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Red	red	O	O	O	O
blood	blood	O	O	O	O
cell	cell	O	O	O	O
and	and	O	O	O	O
serum	serum	O	O	O	O
cholinesterase	cholinesterase	O	O	O	O
levels	levels	O	O	O	O
were	were	O	O	O	O
severely	severely	O	O	O	O
depressed	depressed	O	DISEASE	OTHERS	I
and	and	O	O	O	O
symptoms	symptoms	O	O	O	O
resolved	resolved	O	O	O	O
spontaneously	spontaneously	O	O	O	O
following	following	O	O	O	O
discontinuation	discontinuation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
eye	eye	O	O	O	O
drops	drops	O	O	O	O
.	.	O	O	O	O

